95 related articles for article (PubMed ID: 3121398)
21. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
Toscano V; Balducci R; Bianchi P; Mangiantini A; Sciarra F
J Clin Endocrinol Metab; 1990 Aug; 71(2):288-92. PubMed ID: 2166066
[TBL] [Abstract][Full Text] [Related]
22. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
23. [Plasma renin and aldosterone levels in obese and non-obese women with polycystic ovary syndrome].
Mejia-Montilla J; Reyna-Villasmil E; Torres-Cepeda D; Santos-Bolívar J; Reyna-Villasmil N; Bravo-Henríquez A
Endocrinol Nutr; 2012 Jan; 59(1):21-7. PubMed ID: 22115703
[TBL] [Abstract][Full Text] [Related]
24. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
Vermeulen A; Kaufman JM; Giagulli VA
J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
[TBL] [Abstract][Full Text] [Related]
25. Changes in circulating hormone levels after ovarian wedge resection in patients with polycystic ovary syndrome.
Szilágyi A; Rossmanith W; Csermely T; Csaba I
Arch Gynecol Obstet; 1990; 248(1):31-5. PubMed ID: 2124095
[TBL] [Abstract][Full Text] [Related]
26. Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women.
Murphy A; Cropp CS; Smith BS; Burkman RT; Zacur HA
Fertil Steril; 1990 Jan; 53(1):35-9. PubMed ID: 2136834
[TBL] [Abstract][Full Text] [Related]
27. [Dexamethasone does not normalize disordered LH pulsatility in hyperandrogenemic ovarian insufficiency].
Graf M; Weiers C; Graf C; Umlauf A; Distler W
Geburtshilfe Frauenheilkd; 1992 Jan; 52(1):35-41. PubMed ID: 1547932
[TBL] [Abstract][Full Text] [Related]
28. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome.
Yucel A; Noyan V; Sagsoz N
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):81-6. PubMed ID: 16337726
[TBL] [Abstract][Full Text] [Related]
29. Macrophage migration inhibitory factor in obese and non obese women with polycystic ovary syndrome.
Mejia-Montilla J; Álvarez-Mon M; Reyna-Villasmil E; Torres-Cepeda D; Santos-Bolívar J; Reyna-Villasmil N; Suarez-Torres I; Bravo-Henríquez A
Endocrinol Nutr; 2015 Jan; 62(1):31-7. PubMed ID: 25458401
[TBL] [Abstract][Full Text] [Related]
30. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
31. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Madej P; Owczarek A; Chudek J; Skałba P
Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474
[TBL] [Abstract][Full Text] [Related]
32. Partial reversal of the hypogonadotropic hypogonadism of obese men by administration of corticosuppressive doses of dexamethasone.
Zumoff B; Strain GW; Miller LK; Rosner W; Levit CD; Miller EH; Rosenfeld RS
Int J Obes; 1988; 12(6):525-31. PubMed ID: 3148562
[TBL] [Abstract][Full Text] [Related]
33. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
34. Serum HLA-G levels in women with polycystic ovary syndrome.
Oztekin O; Fenkci SM; Fenkci V; Enli Y; Cabus U
Gynecol Endocrinol; 2015 Mar; 31(3):243-6. PubMed ID: 25403326
[TBL] [Abstract][Full Text] [Related]
35. Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function.
Okon MA; Laird SM; Tuckerman EM; Li TC
Fertil Steril; 1998 Apr; 69(4):682-90. PubMed ID: 9548158
[TBL] [Abstract][Full Text] [Related]
36. Androstenedione concentrations following dexamethasone suppression: correlation with clomiphene responsiveness in women with polycystic ovary syndrome.
Polson DW; Reed MJ; Scanlon MJ; Quiney N; Franks S
Gynecol Endocrinol; 1988 Sep; 2(3):257-64. PubMed ID: 2976245
[TBL] [Abstract][Full Text] [Related]
37. Evidence for insulin resistance in nonobese patients with polycystic ovarian disease.
Jialal I; Naiker P; Reddi K; Moodley J; Joubert SM
J Clin Endocrinol Metab; 1987 May; 64(5):1066-9. PubMed ID: 2951393
[TBL] [Abstract][Full Text] [Related]
38. The androgenic profile of women with non-insulin-dependent diabetes mellitus.
Tok EC; Ertunc D; Evruke C; Dilek S
J Reprod Med; 2004 Sep; 49(9):746-52. PubMed ID: 15493567
[TBL] [Abstract][Full Text] [Related]
39. Evidence of excessive androgen secretion by both the ovary and the adrenal in patients with idiopathic hirsutism.
Pugeat M; Forest MG; Nisula BC; Corniau J; De Peretti E; Tourniaire J
Obstet Gynecol; 1982 Jan; 59(1):46-51. PubMed ID: 6804896
[TBL] [Abstract][Full Text] [Related]
40. Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence.
Avvad CK; Holeuwerger R; Silva VC; Bordallo MA; Breitenbach MM
Gynecol Endocrinol; 2001 Jun; 15(3):170-7. PubMed ID: 11447727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
